ArticleJournal of the National Cancer Institute2020

Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.

Angela Mariotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.